51
|
Buggio L, Somigliana E, Barbara G, Frattaruolo MP, Vercellini P. Oral and depot progestin therapy for endometriosis: towards a personalized medicine. Expert Opin Pharmacother 2017; 18:1569-1581. [DOI: 10.1080/14656566.2017.1381086] [Citation(s) in RCA: 17] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- Laura Buggio
- Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
| | - Edgardo Somigliana
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
- Infertility Unit, Fondazione Ca’ Granda, Ospedale Maggiore Policlinico, Milan, Italy
| | - Giussy Barbara
- Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
| | - Maria Pina Frattaruolo
- Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
| | - Paolo Vercellini
- Fondazione Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy
- Department of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy
| |
Collapse
|
52
|
Eworuke E, Lee JY, Soule L, Popat V, Moeny DG. The impact of the boxed warning on the duration of use for depot medroxprogesterone acetate. Pharmacoepidemiol Drug Saf 2017; 26:827-836. [DOI: 10.1002/pds.4227] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/26/2016] [Revised: 04/17/2017] [Accepted: 04/18/2017] [Indexed: 11/10/2022]
Affiliation(s)
- Efe Eworuke
- Division of Epidemiology II, Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MA USA
| | - Joo-Yeon Lee
- Division of Biometrics VII, Office of Biostatistics; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MA USA
| | - Lisa Soule
- Division of Bone, Reproductive, and Urologic Products; Office of New Drugs, Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MA USA
| | - Vaishali Popat
- Office of New Drugs, Immediate Office; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MA USA
| | - David G. Moeny
- Division of Epidemiology II, Office of Pharmacovigilance and Epidemiology, Office of Surveillance and Epidemiology; Center for Drug Evaluation and Research, Food and Drug Administration; Silver Spring MA USA
| |
Collapse
|
53
|
Practice Guideline: Contraception for Adolescents with Chronic Illness. J Pediatr Health Care 2017; 31:409-420. [PMID: 28433065 DOI: 10.1016/j.pedhc.2017.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/08/2017] [Accepted: 02/08/2017] [Indexed: 11/20/2022]
|
54
|
|
55
|
Abstract
Healthy sexual development is important for adolescents with and without disabilities, yet the topic of sexuality is often ignored in the disabled population. Adolescents with mild or moderate degrees of disability have rates of sexual activity and reproductive health needs comparable to their typically developing peers. Their need for support, risk reduction, and education in sexual health may exceed that of their peers. The medical provider may support healthy sexual development through education, anticipatory guidance, menstrual and contraceptive management, and by expanding the notion of sexuality to include a broader conceptualization of sexual behavior and expression.
Collapse
Affiliation(s)
- Cynthia Holland-Hall
- Section of Adolescent Medicine, Nationwide Children's Hospital, The Ohio State University College of Medicine, 700 Children's Drive, Columbus, OH 43205, USA.
| | - Elisabeth H Quint
- Obstetrics and Gynecology, University of Michigan Medical School, 1500 East Medical Center Drive, Women's L 4000, Ann Arbor, MI 48109, USA
| |
Collapse
|
56
|
Family Planning and Contraception. Fam Med 2017. [DOI: 10.1007/978-3-319-04414-9_108] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
57
|
Lam C, Murthy AS. Depo-Provera (depot medroxyprogesterone acetate) use after bariatric surgery. Open Access J Contracept 2016; 7:143-150. [PMID: 29386945 PMCID: PMC5683152 DOI: 10.2147/oajc.s84097] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022] Open
Abstract
In the US, obesity rates are increasing greatly. The Centers for Disease Control and Prevention estimates that 68.5% of Americans, including 63.9% of adult women older than 20 years, are overweight (body mass index between 25 kg/m2 and 29.9 kg/m2) or obese (body mass index >30 kg/m2). In light of this, it is not surprising that the rates of bariatric surgery have also been increasing. When considering the metabolic changes associated with both bariatric surgery and contraceptive use, in combination with the unique medical considerations of obese women, it is indisputable that clear guidelines are needed when counseling obese patients of reproductive age after bariatric surgery. In this literature review, we focus on depot medroxyprogesterone acetate (DMPA) and the implications of its use in obese women, preweight and postweight loss following bariatric surgery. Both DMPA use and bariatric surgery are known to cause bone loss, but it is still unclear whether there is an additive effect of the two factors on bone loss and whether either of these factors directly leads to an increased risk of bone fracture. The current consensus guidelines do not impose a restriction on the use of DMPA after bariatric surgery. DMPA use is associated with weight gain, and it is unclear whether weight loss blunting occurs with the use of DMPA after bariatric surgery. Prior studies had demonstrated an association with weight gain in adolescents, and therefore, those prescribing DMPA use after bariatric surgery in adolescents should proceed with caution. Adult women do not have a similar response to the use of DMPA. DMPA use has rarely been associated with increased risk of venous thromboembolism (VTE). The obesity-associated increase in VTE should be mitigated by surgically induced weight loss. The concurrent use of DMPA in the post bariatric surgical period should not further increase the risk of VTE.
Collapse
Affiliation(s)
| | - Amitasrigowri S Murthy
- Department of Obstetrics and Gynecology, Bellevue Hospital Center, New York University School of Medicine.,New York University Langone Medical Center, New York, NY, USA
| |
Collapse
|
58
|
Abstract
Adolescents have high rates of unintended pregnancy and face unique reproductive health challenges. Providing confidential contraceptive services to adolescents is important in reducing the rate of unintended pregnancy. Long-acting contraception such as the intrauterine device and contraceptive implant are recommended as first-line contraceptives for adolescents because they are highly effective with few side effects. The use of barrier methods to prevent sexually transmitted infections should be encouraged. Adolescents have limited knowledge of reproductive health and contraceptive options, and their sources of information are often unreliable. Access to contraception is available through a variety of resources that continue to expand.
Collapse
Affiliation(s)
- Shandhini Raidoo
- Department of Obstetrics, Gynecology, and Women's Health, Kapiolani Medical Center for Women and Children, University of Hawaii John A. Burns School of Medicine, 1319 Punahou Street, Suite 824, Honolulu, HI 96826, USA.
| | - Bliss Kaneshiro
- Department of Obstetrics, Gynecology, and Women's Health, Kapiolani Medical Center for Women and Children, University of Hawaii John A. Burns School of Medicine, 1319 Punahou Street, Suite 824, Honolulu, HI 96826, USA
| |
Collapse
|
59
|
Richards MJ, Buyers E. Update on Adolescent Contraception. Adv Pediatr 2016; 63:429-51. [PMID: 27426910 DOI: 10.1016/j.yapd.2016.04.008] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Affiliation(s)
- Molly J Richards
- Section of Adolescent Medicine, Children's Hospital Colorado, University of Colorado School of Medicine, 13123 East 16th Avenue, B025, Aurora, CO 80045, USA.
| | - Eliza Buyers
- Section of Pediatric and Adolescent Gynecology, University of Colorado School of Medicine, 13123 E 16th Avenue B467, Aurora, CO 80045, USA
| |
Collapse
|
60
|
Khodaee M, Edelman GT, Spittler J, Wilber R, Krabak BJ, Solomon D, Riewald S, Kendig A, Borgelt LM, Riederer M, Puzovic V, Rodeo S. Medical Care for Swimmers. SPORTS MEDICINE-OPEN 2016; 2:27. [PMID: 27512647 PMCID: PMC4960281 DOI: 10.1186/s40798-016-0051-2] [Citation(s) in RCA: 20] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 05/12/2016] [Accepted: 07/07/2016] [Indexed: 12/25/2022]
Abstract
Swimming is one of the most popular sports worldwide. Competitive swimming is one of the most watched sports during the Olympic Games. Swimming has unique medical challenges as a result of a variety of environmental and chemical exposures. Musculoskeletal overuse injuries, overtraining, respiratory problems, and dermatologic conditions are among the most common problems swimmers encounter. Although not unique to swimming, overtraining is a serious condition which can have significant negative impact on swimmers' health and performance. This review article is an attempt to discuss various issues that a medical team should consider when caring for swimmers.
Collapse
Affiliation(s)
- Morteza Khodaee
- Department of Family Medicine, University of Colorado School of Medicine, Denver, CO USA
| | - George T Edelman
- Edelman Spine & Orthopaedic Physical Therapy, Dover, DE USA ; Department of Physical Therapy, University of Delaware, Newark, DE USA
| | - Jack Spittler
- Department of Family Medicine, University of Colorado School of Medicine, Denver, CO USA
| | - Randall Wilber
- United State Olympic Committee, Colorado Springs, CO USA
| | - Brian J Krabak
- Rehabilitation, Orthopedics and Sports Medicine, University of Washington and Seattle Children's Sports Medicine, Seattle, WA USA
| | | | - Scott Riewald
- Winter Sports, United States Olympic Committee, Colorado Springs, CO USA
| | - Alicia Kendig
- United State Olympic Committee, Colorado Springs, CO USA
| | - Laura M Borgelt
- Department of Clinical Pharmacy and Family Medicine, University of Colorado Skaggs School of Pharmacy and School of Medicine, Aurora, CO USA
| | - Mark Riederer
- Department of Pediatrics and Orthopaedic Surgery, University of Michigan, Ann Arbor, MI USA
| | - Vladimir Puzovic
- Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
| | - Scott Rodeo
- Sports Medicine and Shoulder Service, Orthopaedic Surgery, The Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY USA ; Tissue Engineering, Regeneration, and Repair Program, The Hospital for Special Surgery, Weill Medical College of Cornell University, New York, NY USA
| |
Collapse
|
61
|
Abstract
The onset of menses for adolescents with physical or intellectual disabilities can affect their independence and add additional concerns for families at home, in schools, and in other settings. The pediatrician is the primary health care provider to explore and assist with the pubertal transition and menstrual management. Menstrual management of both normal and abnormal cycles may be requested to minimize hygiene issues, premenstrual symptoms, dysmenorrhea, heavy or irregular bleeding, contraception, and conditions exacerbated by the menstrual cycle. Several options are available for menstrual management, depending on the outcome that is desired, ranging from cycle regulation to complete amenorrhea. The use of medications or the request for surgeries to help with the menstrual cycles in teenagers with disabilities has medical, social, legal, and ethical implications. This clinical report is designed to help guide pediatricians in assisting adolescent females with intellectual and/or physical disabilities and their families in making decisions related to successfully navigating menarche and subsequent menstrual cycles.
Collapse
|
62
|
Bommaraju A, Malat J, Mooney JL. Reproductive Life Plan Counseling and Effective Contraceptive Use among Urban Women Utilizing Title X Services. Womens Health Issues 2016; 25:209-15. [PMID: 25965154 DOI: 10.1016/j.whi.2015.02.005] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/05/2014] [Revised: 02/13/2015] [Accepted: 02/25/2015] [Indexed: 11/15/2022]
Abstract
BACKGROUND Although the Centers for Disease Control and Prevention and the U.S. Office of Population Affairs recommend inclusion of reproductive life plan counseling (RLPC) in all well-woman health care visits, no studies have examined the effect of RLPC sessions on the decision to use effective contraception at publicly funded family planning sites. RLPC could be a particularly impactful intervention for disadvantaged social groups who are less likely to use the most effective contraceptive methods. METHODS Using data from 771 nonpregnant, non-pregnancy-seeking women receiving gynecological services in the Cincinnati-Hamilton County Reproductive Health and Wellness Program, multinomial logistic regression models compared users of nonmedical/no method with users of 1) the pill, patch, or ring, 2) depot medroxyprogesterone acetate, and 3) long-acting reversible contraception (LARC). The effect of RLPC on the use of each form of contraception, and whether it mediated the effect of race/ethnicity and education on contraceptive use, was examined while controlling for age, insurance status, and birth history. The interaction between RLPC and race/ethnicity and the interaction between RLPC and educational attainment was also assessed. FINDINGS RLPC was not associated with contraceptive use. The data suggested that RLPC may increase LARC use over nonmedical/no method use. RLPC did not mediate or moderate the effect of race/ethnicity or educational attainment on contraceptive use in any comparison. CONCLUSIONS In this system of publicly funded family planning clinics, RLPC seems not to encourage effective method use, providing no support for the efficacy of the RLPC intervention. The results suggest that this intervention requires further development and evaluation.
Collapse
Affiliation(s)
- Aalap Bommaraju
- Department of Sociology, University of Cincinnati, Cincinnati, Ohio; Cincinnati-Hamilton County Reproductive Health and Wellness Program, Cincinnati, Ohio.
| | - Jennifer Malat
- Department of Sociology, University of Cincinnati, Cincinnati, Ohio; Kunz Center for Social Research, University of Cincinnati, Cincinnati, Ohio
| | | |
Collapse
|
63
|
Quint EH. Adolescents with Special Needs: Clinical Challenges in Reproductive Health Care. J Pediatr Adolesc Gynecol 2016; 29:2-6. [PMID: 26542013 DOI: 10.1016/j.jpag.2015.05.003] [Citation(s) in RCA: 34] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/24/2015] [Revised: 04/21/2015] [Accepted: 05/05/2015] [Indexed: 11/24/2022]
Abstract
Adolescents with special needs have unique reproductive health care needs related to their physical and cognitive issues. This review discusses some of the most common concerns that are encountered in clinical practice, as the clinician will partner with the adolescent and her family to guide her through the pubertal transition and to help navigate the risks and rights of reproduction. Families often seek anticipatory guidance before menarche on menstrual hygiene, abuse risk and sexuality and can be reassured that most teens with special needs do very well with menstruation. The clinician needs to evaluate the teenager's reproductive knowledge as well her risk for abuse and coercion and her ability to consent to sexual activity, if she requests contraception. Menstrual management is mostly based on the impact of the menstrual cycles on the teenager's life and activities. The adolescents may have a decreased ability to tolerate menses or pain, or experience changes in seizure pattern or altered mood. Hormonal treatment is often used to assist with menstrual hygiene, cyclical mood changes or dysmenorrhea. The goal of treatment can be complete amenorrhea, alleviate pain or regulate and decrease menstrual flow. The unique risks and benefits of hormonal treatment for this special population are highlighted.
Collapse
Affiliation(s)
- Elisabeth H Quint
- Department of Obstetrics and Gynecology, University of Michigan Medical School, Ann Arbor, Michigan.
| |
Collapse
|
64
|
Downs RW, Yazbeck CF. Osteoporosis After Long-Term Depot Medroxyprogesterone: We Need More Data on Fracture Risk. J Womens Health (Larchmt) 2015; 24:619-20. [DOI: 10.1089/jwh.2015.29000-rwd] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022] Open
Affiliation(s)
- Robert W. Downs
- School of Medicine, Virginia Commonwealth University, Richmond, Virginia
| | - Cynthia F. Yazbeck
- School of Medicine, Virginia Commonwealth University, Richmond, Virginia
| |
Collapse
|
65
|
Fouquier KF, Camune BD. Meeting the Reproductive Needs of Female Adolescents With Neurodevelopmental Disabilities. J Obstet Gynecol Neonatal Nurs 2015; 44:553-563. [DOI: 10.1111/1552-6909.12657] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
|
66
|
Kaneshiro B, Salcedo J. Contraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health Outcomes. CURRENT OBSTETRICS AND GYNECOLOGY REPORTS 2015; 4:53-60. [PMID: 27635305 PMCID: PMC5021306 DOI: 10.1007/s13669-015-0112-4] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
Abstract
Adolescent pregnancy rates in the U.S. have reached an all-time low from their peak in the 1980s and 1990s. However, the U.S. maintains the highest rate of teenage pregnancy among developed nations. Adolescents experience higher typical use failure rates for user-dependent contraceptives compared to their adult counterparts. Long-acting reversible contraception (LARC), IUDs and implants, have failure rates that are both very low and independent of user age. In settings where the most effective methods are prioritized and access barriers are removed, the majority of adolescents initiate LARC. Use of LARC by adolescents significantly reduces rates of overall and repeat teen pregnancy. All methods of contraception are safe for use in teens, including IUDs and DMPA. Dual use of LARC and barrier methods to reduce risk of sexually transmitted infection, is the optimal contraceptive strategy for most adolescents. Adolescent access to evidence-based and confidential contraceptive services, provided in a manner that respects autonomy, is a vital public health goal.
Collapse
Affiliation(s)
- Bliss Kaneshiro
- Department of Obstetrics, Gynecology and Women’s Health University of Hawaii John A. Burns School of Medicine, 1319 Punahou Street #824, Honolulu, HI 96826, Phone: (808) 203-6500, Fax: (808) 955-2175
| | - Jennifer Salcedo
- Department of Obstetrics, Gynecology and Women’s Health University of Hawaii John A. Burns School of Medicine, 1319 Punahou Street #824, Honolulu, HI 96826, Phone: (808) 203-6500, Fax: (808) 955-2175
| |
Collapse
|
67
|
Injectable Contraception: Current Practices and Future Trends. CURRENT OBSTETRICS AND GYNECOLOGY REPORTS 2015. [DOI: 10.1007/s13669-014-0106-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
68
|
Greenberg GM, Ursu A, Hertz MI. Family Planning and Contraception. Fam Med 2014. [DOI: 10.1007/978-1-4939-0779-3_108-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|